AnalystsStephen BrozakStephen Brozak's Stock Forecasts
AnalystsStephen Brozak
Sectors:
Industries:
Analyst Ranking
Top 31%
#1565 out of 5177 analysts
Average Return
+357.81%
Win Rate
100%3 out of 3
Risk vs Reward
Poor
Good
Stephen Brozak's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cidara Therapeutics IncCDTX | +1,006.37% | $19.93 | $220.50 | 2024-12-04 - 2025-12-04 | Strong Buy |
Paratek Pharmaceuticals IncPRTK | +51.32% | $4.17 | $6.31 | 2020-01-07 - 2021-01-08 | Buy |
Cidara Therapeutics IncCDTX | +15.75% | $146.00 | $123.00 | 2017-07-27 - 2017-08-11 | Sell |
Stephen Brozak Analyst Color
Get additional color on Stephen Brozak's coverage of popular stocks
Stephen Brozak's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cidara Therapeutics IncCDTX | 4 | Strong Buy | $45.00 | N/A | Maintains | a year ago |
Arcturus Therapeutics Holdings IncARCT | 1 | Hold | $31.00 | N/A | Downgrades | 6 years ago |
Paratek Pharmaceuticals IncPRTK | 1 | Buy | $6.00 | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.